InsidersTradesSigma
Follow the MAINZ BIOMED N.V. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). The latest transaction was reported on 20 January 2026 (Acquisition). Among the most active insiders: Donahue Kevin Michael. The full history is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations